(ORCL) Oracle - Overview
Stock: Database, Cloud, ERP, Middleware, Hardware
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.00% |
| Yield on Cost 5y | 3.37% |
| Yield CAGR 5y | 12.17% |
| Payout Consistency | 97.6% |
| Payout Ratio | 29.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 57.6% |
| Relative Tail Risk | -17.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -28.61 |
| Character TTM | |
|---|---|
| Beta | 1.386 |
| Beta Downside | 1.346 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.69% |
| CAGR/Max DD | 0.43 |
Description: ORCL Oracle January 26, 2026
Oracle Corporation (NYSE:ORCL) delivers a broad portfolio of enterprise-technology solutions, spanning cloud-based SaaS applications (ERP, EPM, SCM, HCM, NetSuite, Health, Sales, Service, Marketing), cloud-infrastructure services (autonomous database, compute, storage, networking, AI/ML, IoT, blockchain), on-premise software licenses, and engineered hardware systems. The company sells directly and via partners to corporations, governments, and schools, and maintains a strategic alliance with Metron, Inc. Founded in 1977, Oracle is now headquartered in Austin, Texas.
Key recent metrics (FY 2025): total revenue $44.1 billion, with cloud-services and license revenue growing 6 % YoY to $30.2 billion; subscription-based ARR now exceeds $30 billion, up 12 % year-over-year; operating margin remains robust at ~38 %; free cash flow reached $9.4 billion, supporting a $2.5 billion share-repurchase program. Macro-level, enterprise IT spending is projected to rise ~5 % annually through 2027, while AI-enabled cloud adoption is accelerating, benefitting vendors with integrated autonomous-database and machine-learning capabilities-areas where Oracle has positioned itself as a leader.
For a deeper quantitative view of Oracle’s valuation dynamics, explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 15.43b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -12.86 > 1.0 |
| NWC/Revenue: -5.62% < 20% (prev -10.10%; Δ 4.48% < -1%) |
| CFO/TA 0.11 > 3% & CFO 22.30b > Net Income 15.43b |
| Net Debt (105.14b) to EBITDA (27.00b): 3.89 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago 1.85% < -2% |
| Gross Margin: 68.54% > 18% (prev 0.71%; Δ 6783 % > 0.5%) |
| Asset Turnover: 34.52% > 50% (prev 37.00%; Δ -2.47% > 0%) |
| Interest Coverage Ratio: 5.51 > 6 (EBITDA TTM 27.00b / Interest Expense TTM 3.85b) |
Altman Z'' 0.73
| A: -0.02 (Total Current Assets 34.37b - Total Current Liabilities 37.80b) / Total Assets 204.98b |
| B: -0.05 (Retained Earnings -9.36b / Total Assets 204.98b) |
| C: 0.12 (EBIT TTM 21.22b / Avg Total Assets 176.73b) |
| D: 0.17 (Book Value of Equity 29.95b / Total Liabilities 174.53b) |
| Altman-Z'' Score: 0.73 = B |
Beneish M -3.06
| DSRI: 1.04 (Receivables 9.44b/8.18b, Revenue 61.02b/54.93b) |
| GMI: 1.04 (GM 68.54% / 71.27%) |
| AQI: 0.76 (AQ_t 0.50 / AQ_t-1 0.66) |
| SGI: 1.11 (Revenue 61.02b / 54.93b) |
| TATA: -0.03 (NI 15.43b - CFO 22.30b) / TA 204.98b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of ORCL shares?
Over the past week, the price has changed by -11.57%, over one month by -19.48%, over three months by -39.86% and over the past year by -7.33%.
Is ORCL a buy, sell or hold?
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ORCL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 288.3 | 86.4% |
| Analysts Target Price | 288.3 | 86.4% |
| ValueRay Target Price | 164.5 | 6.3% |
ORCL Fundamental Data Overview January 31, 2026
P/E Forward = 24.7525
P/S = 7.9584
P/B = 16.2127
P/EG = 1.5586
Revenue TTM = 61.02b USD
EBIT TTM = 21.22b USD
EBITDA TTM = 27.00b USD
Long Term Debt = 99.98b USD (from longTermDebt, last quarter)
Short Term Debt = 8.09b USD (from shortTermDebt, last quarter)
Debt = 124.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 105.14b USD (from netDebt column, last quarter)
Enterprise Value = 590.21b USD (485.59b + Debt 124.39b - CCE 19.77b)
Interest Coverage Ratio = 5.51 (Ebit TTM 21.22b / Interest Expense TTM 3.85b)
EV/FCF = -44.78x (Enterprise Value 590.21b / FCF TTM -13.18b)
FCF Yield = -2.23% (FCF TTM -13.18b / Enterprise Value 590.21b)
FCF Margin = -21.60% (FCF TTM -13.18b / Revenue TTM 61.02b)
Net Margin = 25.28% (Net Income TTM 15.43b / Revenue TTM 61.02b)
Gross Margin = 68.54% ((Revenue TTM 61.02b - Cost of Revenue TTM 19.19b) / Revenue TTM)
Gross Margin QoQ = 66.53% (prev 67.28%)
Tobins Q-Ratio = 2.88 (Enterprise Value 590.21b / Total Assets 204.98b)
Interest Expense / Debt = 0.85% (Interest Expense 1.06b / Debt 124.39b)
Taxrate = 3.26% (207.0m / 6.34b)
NOPAT = 20.53b (EBIT 21.22b * (1 - 3.26%))
Current Ratio = 0.91 (Total Current Assets 34.37b / Total Current Liabilities 37.80b)
Debt / Equity = 4.15 (Debt 124.39b / totalStockholderEquity, last quarter 29.95b)
Debt / EBITDA = 3.89 (Net Debt 105.14b / EBITDA 27.00b)
Debt / FCF = -7.98 (negative FCF - burning cash) (Net Debt 105.14b / FCF TTM -13.18b)
Total Stockholder Equity = 22.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.73% (Net Income 15.43b / Total Assets 204.98b)
RoE = 67.59% (Net Income TTM 15.43b / Total Stockholder Equity 22.82b)
RoCE = 17.28% (EBIT 21.22b / Capital Employed (Equity 22.82b + L.T.Debt 99.98b))
RoIC = 17.12% (NOPAT 20.53b / Invested Capital 119.88b)
WACC = 8.94% (E(485.59b)/V(609.97b) * Re(11.02%) + D(124.39b)/V(609.97b) * Rd(0.85%) * (1-Tc(0.03)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.85%
Fair Price DCF = unknown (Cash Flow -13.18b)
EPS Correlation: 63.90 | EPS CAGR: 20.30% | SUE: 4.0 | # QB: 1
Revenue Correlation: 92.75 | Revenue CAGR: 11.96% | SUE: -0.38 | # QB: 0
EPS current Year (2026-05-31): EPS=7.37 | Chg30d=+0.004 | Revisions Net=-3 | Growth EPS=+22.3% | Growth Revenue=+16.6%
EPS next Year (2027-05-31): EPS=7.93 | Chg30d=-0.029 | Revisions Net=-2 | Growth EPS=+7.6% | Growth Revenue=+28.9%